Results 71 to 80 of about 15,615 (185)

Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model

Frontiers in Neuroanatomy
Parkinson’s disease (PD) is a neurodegenerative condition characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) of the brain, manifesting itself with both motor and non-motor symptoms.
Maria E. Bianchetti, Ana Flavia F. Ferreira, Luiz R. G. Britto   +2 more
doaj   +1 more source

Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model. [PDF]

Int J Mol Sci, 2023
Silva da Fonsêca V, Goncalves VC, Augusto Izidoro M, Guimarães de Almeida AC, Luiz Affonso Fonseca F, Alexandre Scorza F, Finsterer J, Scorza CA.   +7 more
europepmc   +1 more source

Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson's disease. [PDF]

Sci Rep, 2023
Janda E, Parafati M, Martino C, Crupi F, George William JN, Reybier K, Arbitrio M, Mollace V, Boutin JA.   +8 more
europepmc   +1 more source

NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats

Clinical Interventions in Aging, 2013
Na Wu, Lu Song, Xinxin Yang, Weien Yuan, Zhenguo Liu Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China Background: Parkinson’s disease is a neurodegenerative ...
Wu N, Song L, Yang X, Yuan W, Liu Z
doaj  

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. [PDF]

Sci Rep, 2023
Wu KJ, Hung TW, Wang YS, Chen YH, Bae EK, Yu SJ.   +5 more
europepmc   +1 more source

Exploring Cognitive and Affective Outcomes Following Bilateral 6-Hydroxydopamine Lesions of the Substance Nigra or Striatum in Rats. [PDF]

J Neurosci Res
de Mattos BA, Del Bel E, Milani H, de Oliveira RMW, Bonato JM.   +4 more
europepmc   +1 more source

Effectiveness of Albumin-Fused Thioredoxin against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro. [PDF]

Int J Mol Sci, 2023
Sakakibara O, Shimoda M, Yamamoto G, Higashi Y, Ikeda-Imafuku M, Ishima Y, Kawahara M, Tanaka KI.   +7 more
europepmc   +1 more source

Ginkgolide B Attenuates 6-Hydroxydopamine-Induced Cellular Damage and Modulates Oxidant-Evoked Ca²⁺ Signalling in SH-SY5Y Cells. [PDF]

Curr Issues Mol Biol
Çınar R, Göztepe M, Ahlatcı A, Yıldızhan K.   +3 more
europepmc   +1 more source

CRISPR/Cas9-mediated knockout of NEAT1 attenuates neurotoxicity in 6-hydroxydopamine model of Parkinson's disease. [PDF]

Iran J Basic Med Sci
Samareh A, Nematollahi MH, Pourghadamyari H, Rastegar S, Ebrahimi H, Hadizadeh M, Wang H, Tao L, Sasan H, Asadikaram G.   +9 more
europepmc   +1 more source

Amphiregulin blockade decreases the levodopa-induced dyskinesia in a 6-hydroxydopamine Parkinson's disease mouse model. [PDF]

CNS Neurosci Ther, 2023
Kambey PA, Liu WY, Wu J, Tang C, Buberwa W, Saro A, Nyalali AMK, Gao D.   +7 more
europepmc   +1 more source